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COMMENTARY AND VIEWS
Comment on “mt-Keima detects PINK1-PRKN mitophagy in vivo with greater 
sensitivity than mito-QC”
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One aspect of selective autophagy that has garnered intense 
interest is mitochondrial autophagy (mitophagy), particularly 
PINK1-PRKN-mediated mitophagy as this has direct implica-
tions for Parkinson disease. However, initial studies of differ-
ent mitophagy reporters in this context have resulted in 
a perceived conflict of results/outcomes and conclusions. 
A recent article by Liu et al. attempts to reconcile these 
discordant findings by comparing side-by-side two mitophagy 
reporter systems, mt-Keima and mito-QC [1]. A direct com-
parison of the reporter systems is certainly warranted, and in 
the cell-based analyses used in Liu et al. that involve PRKN 
overexpression and flow cytometry, it is encouraging to see 
that mt-Keima produces a robust signal. However, the head-
line claim that mito-QC is insufficiently sensitive for monitor-
ing PINK1-PRKN-dependent mitophagy should be brought 
into balance. mito-QC has been used in multiple published 
studies by independent groups as part of a series of experi-
ments to clearly and reliably show increased mitophagy, either 
in the presence or absence of PINK1-PRKN, and under endo-
genous or overexpressed PRKN conditions. Readers are 
encouraged to examine some of the many published, well 
controlled and validated studies [2–22].
Additionally, Liu et al. repeated their own results demon-
strating that exhaustive exercise induces PINK1-dependent 
mitophagy in the heart of mt-Keima mice. This is very 
encouraging given the difficult reproducibility associated 
with this type of exhaustive exercise study. However, we 
would like to point out that comparisons between mito-QC 
and mt-Keima should be made cautiously and are somewhat 
akin to comparing apples to oranges. One compelling reason 
is because the models have been generated and maintained 
using different mouse strains (C57BL/6 j-ntac versus FVB/NJ 
for mt-Keima [12,23]). Compared to C57 lines, FVB mice are 
naturally hyperactive with circadian dysregulation and beha-
vioral defects [24–26], display neuroanatomical abnormalities 
[27], retinal neurodegeneration and blindness [28]. It is 
important to note that significant differences also exist 
between FVB and C57 lines in adapting to and entrainment 
for treadmill exercise paradigms [29], including mitochon-
drial differences in muscle tissues [30] and divergent cardiac 
physiology [31]. We would like to refer the reader to the 
article by Enriquez that highlights the importance of consid-
ering genetic backgrounds in order to meaningfully compare 
data [32].
Finally, we would like to address the notion by Liu et al. 
that McWilliams et al., 2018 and Lee et al., 2018 have gener-
ated controversy in terms of the PINK1-PRKN mitophagy 
pathway [7,13]. From our perspective there is no controversy 
that multiple mitophagy pathways exist. The main conclusion 
of these papers was that the PINK1-PRKN pathway did not 
regulate mitophagy under basal conditions. This is the exact 
same observation that Liu et al. demonstrate in their current 
study: in the absence of exhaustive exercise, mitophagy levels 
in heart tissues of mt-Keima mice remain constant regardless 
of the presence or absence of PINK1; i.e., their basal level of 
mitophagy is independent of PINK1. We would also like to 
highlight work from the Goessling Lab that recently generated 
zebrafish models of mitophagy and compared Keima- and 
tandem mCherry-GFP-based reporters [33]. Here, the authors 
noted that both reporters faithfully monitored mitophagy and, 
additionally, the characterized mitophagy was determined to 
be independent of PINK1 and PRKN, instead requiring 
BNIP3. Thus, taking into account multiple publications from 
independent laboratories, using three popular animal models, 
we think that all demonstrate the same main conclusion, 
which is that the PINK1-PRKN pathway does not significantly 
contribute to basal mitophagy.
We think that both reporters have merit and, under different 
scenarios, use of one type of reporter may be more advanta-
geous than the other. Due to loss of signal upon fixation, use of 
the mt-Keima mouse requires very strict time-dependent pre-
paration and analysis, which may not be achievable in some 
laboratories. This is where use of mito-QC may be preferable, 
particularly when immunohistochemistry is required to identify 
specific cell types or additional cellular components. Targeting 
mitophagy is likely to have genuine translational importance, 
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most notably for neurodegenerative disorders, particularly given 
the 99.7% failure rate for drugs in this area [34]. Accordingly, 
despite the limitations of both reporter systems, a carefully 
considered discussion is essential. Both reporter systems have 
contributed to our understanding of physiological mitophagy 
and are well-positioned to continue unraveling the mysteries of 
mitophagy in health and disease.
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